Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis.

Among factors that could influence and predict the efficacy of pegvisomant therapy in controlling acromegaly, a central role of baseline IGF-1 values on the probability of achieving a biochemical control of acromegaly during the treatment with pegvisomant was identified, in a real-life setting.